Patient Counseling Information Section of Labeling for Human Prescription Drug and Biological Products — Content and Format
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
December 10, 2014
April 27, 2020
91c267ae-e99d-4508-b31c-721b7da25d2b
Related Documents
Clinical Pharmacology Labeling for Human Prescription Drug and Biological Products — Content and Format
Guidance DocumentDecember 5, 2016Center for Drug Evaluation and Research
Instructions for Use — Patient Labeling for Human Prescription Drug and Biological Products — Content and Format
Guidance DocumentJuly 15, 2022Center for Drug Evaluation and Research
Providing Regulatory Submissions in Electronic Format — Submissions Under Section 745A(a) of the Federal Food, Drug, and Cosmetic Act
Guidance DocumentDecember 18, 2014Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.